BioPrime Raises USD 6 Million to Expand Business
By Rediff Money Desk, New Delhi Oct 08, 2024 15:17
BioPrime, a biologicals startup, raises USD 6 million to expand its business and develop novel biofungicides & bioinsecticides. The investment will also fuel research in crop protection and expansion into new markets.
New Delhi, Oct 8 (PTI) Startup BioPrime on Tuesday said that it has raised USD 6 million from investors to expand its business.
BioPrime raised USD 6 million in Series A round, led by Edaphon, with equal participation from existing investors Omnivore and Inflexor, the company said in a statement.
BioPrime was founded in 2016 by Dr Renuka Diwan, Dr Amit Shinde and Dr Shekhar Bhosale. The founders have experience in plant and microbe biotechnology.
The company is a biologicals startup that builds climate resilience in crops by using targeted physiology-modulating biomolecules.
This investment will fuel BioPrime's research in the crop protection segment, focusing on the co-development of novel biofungicides & bioinsecticides.
"The company plans to launch its existing range of innovative biostimulants in North America, Brazil & Southeast Asia with trials in the US currently underway."
Furthermore, BioPrime plans to advance and accelerate product development based on BioNexus, the patented technology platform, which has identified over 170 novel microbial strains from its library of close to 18,000 strains.
Renuka Diwan, Co-founder & CEO, said, "We will continue to pursue our strategic priorities of accelerating the development of industry solutions in the biologicals space. We look forward to enhancing the offerings to our existing B2B customers & entering into strategic co-development & licensing with industry players.
BioPrime raised USD 6 million in Series A round, led by Edaphon, with equal participation from existing investors Omnivore and Inflexor, the company said in a statement.
BioPrime was founded in 2016 by Dr Renuka Diwan, Dr Amit Shinde and Dr Shekhar Bhosale. The founders have experience in plant and microbe biotechnology.
The company is a biologicals startup that builds climate resilience in crops by using targeted physiology-modulating biomolecules.
This investment will fuel BioPrime's research in the crop protection segment, focusing on the co-development of novel biofungicides & bioinsecticides.
"The company plans to launch its existing range of innovative biostimulants in North America, Brazil & Southeast Asia with trials in the US currently underway."
Furthermore, BioPrime plans to advance and accelerate product development based on BioNexus, the patented technology platform, which has identified over 170 novel microbial strains from its library of close to 18,000 strains.
Renuka Diwan, Co-founder & CEO, said, "We will continue to pursue our strategic priorities of accelerating the development of industry solutions in the biologicals space. We look forward to enhancing the offerings to our existing B2B customers & entering into strategic co-development & licensing with industry players.
Source: PTI
Read More On:
DISCLAIMER - This article is from a syndicated feed. The original source is responsible for accuracy, views & content ownership. Views expressed may not reflect those of rediff.com India Limited.
You May Like To Read
TODAY'S MOST TRADED COMPANIES
- Company Name
- Price
- Volume
- Vodafone Idea L
- 9.50 (+ 3.60)
- 98491250
- GTL Infrastructure
- 2.32 (+ 4.98)
- 74918021
- Advik Capital
- 3.25 (+ 7.97)
- 34086998
- Jaiprakash Power Ven
- 20.03 (+ 8.45)
- 26873790
- Spicejet Ltd.
- 62.80 (+ 9.10)
- 26113604
MORE NEWS
Mandaviya Pushes for Integrated Employment &...
Union Minister Mandaviya advocates for integrating central and state portals to provide...
Rajasthan Seeks ASEAN Investment: Opportunities...
Rajasthan Minister Rajyavardhan Rathore calls for investment from ASEAN nations,...
Torrent Power Wins 2,000 MW Pumped Storage...
Torrent Power secures a contract from the Maharashtra government to supply 2,000 MW...